Zentek Ltd. (ZTEK)
USD 1.78
(1.72%)
USD 1.78
(1.72%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -301.26 Thousand CAD | 64.85% |
| 2022 | -857.01 Thousand CAD | -211.59% |
| 2021 | -275.04 Thousand CAD | -121.02% |
| 2020 | -124.44 Thousand CAD | -400.2% |
| 2019 | -24.87 Thousand CAD | -369.77% |
| 2018 | -5296.00 CAD | 12.74% |
| 2017 | -6069.00 CAD | 37.52% |
| 2016 | -9714.00 CAD | 14.67% |
| 2015 | -11.38 Thousand CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -1.74 Million CAD | 88.15% |
| 2023 Q1 | -122.59 Thousand CAD | -56.74% |
| 2023 FY | -301.26 Thousand CAD | 64.85% |
| 2023 Q4 | -125.12 Thousand CAD | -149.77% |
| 2023 Q3 | -50.09 Thousand CAD | 97.2% |
| 2023 Q2 | -1.79 Million CAD | -1361.27% |
| 2022 Q3 | -252.97 Thousand CAD | -118.07% |
| 2022 Q4 | -78.21 Thousand CAD | 69.08% |
| 2022 FY | -857.01 Thousand CAD | -211.59% |
| 2022 Q1 | -122.59 Thousand CAD | 82.69% |
| 2022 Q2 | -116 Thousand CAD | 5.37% |
| 2021 Q3 | 434.1 Thousand CAD | 512.86% |
| 2021 Q4 | -708.42 Thousand CAD | -263.19% |
| 2021 Q2 | 70.83 Thousand CAD | 199.0% |
| 2021 Q1 | -71.55 Thousand CAD | 26.1% |
| 2021 FY | -275.04 Thousand CAD | -121.02% |
| 2020 Q1 | -5231.00 CAD | 55.32% |
| 2020 FY | -124.44 Thousand CAD | -400.2% |
| 2020 Q2 | -10.52 Thousand CAD | -101.28% |
| 2020 Q3 | -14.21 Thousand CAD | -35.02% |
| 2020 Q4 | -96.82 Thousand CAD | -581.08% |
| 2019 Q4 | -11.7 Thousand CAD | -9.11% |
| 2019 Q3 | -10.73 Thousand CAD | -722.22% |
| 2019 Q1 | -1136.00 CAD | 30.69% |
| 2019 Q2 | -1305.00 CAD | -14.88% |
| 2019 FY | -24.87 Thousand CAD | -369.77% |
| 2018 Q2 | -1090.00 CAD | 0.0% |
| 2018 Q3 | -1353.00 CAD | -24.13% |
| 2018 Q4 | -1639.00 CAD | -21.14% |
| 2018 FY | -5296.00 CAD | 12.74% |
| 2018 Q1 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 FY | -6069.00 CAD | 37.52% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 FY | -9714.00 CAD | 14.67% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 FY | -11.38 Thousand CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | 100.535% |
| AngioDynamics, Inc. | 154.69 Million USD | 100.195% |
| AtriCure, Inc. | 300.37 Million USD | 100.1% |
| Avinger, Inc. | 2 Million USD | 115.041% |
| Azenta, Inc. | 263.14 Million USD | 100.114% |
| BioLife Solutions, Inc. | 46.75 Million USD | 100.644% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 100.013% |
| Daxor Corporation | 1.1 Million USD | 127.302% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | 103.318% |
| Femasys Inc. | 691.9 Thousand USD | 143.541% |
| GlucoTrack, Inc. | -13 Thousand USD | -2217.415% |
| Harvard Bioscience, Inc. | 60.86 Million USD | 100.495% |
| Hologic, Inc. | 2.22 Billion USD | 100.014% |
| ICU Medical, Inc. | 739.87 Million USD | 100.041% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 100.006% |
| KORU Medical Systems, Inc. | 16.7 Million USD | 101.803% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | 100.237% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | -152.465% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | -152.465% |
| Masimo Corporation | 1 Billion USD | 100.03% |
| Microbot Medical Inc. | -106 Thousand USD | -184.211% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | 100.91% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 100.052% |
| Nephros, Inc. | 8.4 Million USD | 103.584% |
| NovoCure Limited | 381.05 Million USD | 100.079% |
| NEXGEL, Inc. | 619 Thousand USD | 148.669% |
| NEXGEL, Inc. | 619 Thousand USD | 148.669% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 46.01% |
| OraSure Technologies, Inc. | 179.42 Million USD | 100.168% |
| Pro-Dex, Inc. | 14.55 Million USD | 102.07% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 75.04% |
| Predictive Oncology Inc. | 1.14 Million USD | 126.304% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | 105.196% |
| QuidelOrtho Corporation | 1.49 Billion USD | 100.02% |
| Repligen Corporation | 315.22 Million USD | 100.096% |
| Sanara MedTech Inc. | 57.13 Million USD | 100.527% |
| STAAR Surgical Company | 252.65 Million USD | 100.119% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 66.198% |
| Utah Medical Products, Inc. | 30.03 Million USD | 101.003% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 100.014% |
| Jin Medical International Ltd. | 6.78 Million USD | 104.44% |